Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration

被引：0

作者：

Lee, Sang Hyeok ^{[1
]}

Lee, Mee Yon ^{[1
]}

机构：

[1] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea

来源：

EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2025年 / 35卷 / 01期

关键词：

Macular hole; anti-VEGF; brolucizumab; RETINAL-PIGMENT EPITHELIUM; RANIBIZUMAB; DETACHMENT;

D O I：

10.1177/11206721241286708

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date.Case description A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole.Outcome Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated.Conclusion Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.

引用

页码：NP16 / NP19

页数：4

共 50 条

[41] Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Enriquez, Ana Bety
Baumal, Caroline R.
Crane, Ashley M.
Witkin, Andre J.
Lally, David R.
Liang, Michelle C.
Enriquez, Jose Ramon
Eichenbaum, David A.
JAMA OPHTHALMOLOGY, 2021, 139 (04) : 441 - 448
[42] Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
Avery, RL
Pieramici, DJ
Rabena, MD
Castellarin, AA
Nasir, MA
Giust, MJ
OPHTHALMOLOGY, 2006, 113 (03) : 363 - 372
[43] Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry
Joshi, Shrinivas
Verma, Lalit
Ayachit, Guruprasad
Salvi, Rajashree
Asad, Yusra
Gupta, Avnindra
Patil, Anuja
Ayachit, Apoorva
INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (10) : 3375 - 3380
[44] The effect of brolucizumab applied by microvolume injection or infusion in patients with neovascular age-related macular degeneration
Jhaveri, Chirag
Wenzel, Andreas
Weichselberger, Andreas
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[45] Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration
Barthelmes, Daniel
Walton, Richard J.
Arnold, Jennifer J.
Mcallister, Ian L.
Simpson, Judy M.
Campain, Anna
Hunyor, Alex P.
Guymer, Robyn
Essex, Rohan W.
Morlet, Nigel
Gillies, Mark C.
OPHTHALMOLOGY, 2014, 121 (10) : 2073 - 2074
[46] Aflibercept for Intravitreal InjectionIn Neovascular Age-Related Macular Degeneration
James E. Frampton
Drugs & Aging, 2012, 29 : 839 - 846
[47] Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration
Hirono, Kazushi
Maruyama-Inoue, Maiko
Yanagi, Yasuo
Kadonosono, Kazuaki
PLOS ONE, 2024, 19 (04):
[48] Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
Kabanarou, Stamatina A.
Xirou, Tina
Mangouritsas, George
Garnavou-Xirou, Christina
Boutouri, Eirini
Gkizis, Ilias
Chatziralli, Irini
CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 911 - 915
[49] Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Cheolmin Yun
Jaeryung Oh
Kwang-Eon Choi
Soon-Young Hwang
Seong-Woo Kim
Kuhl Huh
BMC Ophthalmology, 16
[50] Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration
Unlu, Cihan
Erdogan, Gurkan
Gunay, Betul Onal
Akcay, Betul Ilkay Sezgin
Kardes, Esra
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (04) : 849 - 851

← 1 2 3 4 5 →